Share this video  

VJOncology is committed to improving our service to you

GU Cancers 2020 | Optimizing immunotherapy duration

Hans Hammers, MD, PhD, The University of Texas Southwestern, Dallas, TX, discusses the importance of individualized approaches to determine the best duration of immunotherapy treatment. Specifically, he focuses on the need to optimize patient outcomes and reducing unnecessary costs. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter